Liquidia Announces Generic Treprostinil Injection Now Also Available for Subcutaneous Route of AdministrationGlobeNewsWire • 05/24/21
Liquidia Technologies, Inc. (LQDA) CEO Damian deGoa on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/13/21
Liquidia Reports First Quarter 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire • 05/13/21
Liquidia Resubmits New Drug Application for LIQ861 (treprostinil) Inhalation Powder for the Treatment of Pulmonary Arterial HypertensionGlobeNewsWire • 05/10/21
Liquidia Corporation to Report First Quarter 2021 Financial Results on May 13, 2021GlobeNewsWire • 05/06/21
Liquidia Announces Generic Treprostinil Injection Will Be Available for Subcutaneous Route of AdministrationGlobeNewsWire • 03/30/21
Liquidia Technologies, Inc. (LQDA) CEO Damian deGoa on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/23/21
Liquidia Corporation Reports Full-Year 2020 Financial Results and Provides Corporate UpdateGlobeNewsWire • 03/23/21
Liquidia Corporation to Host 2020 Financial Results Conference Call on March 23, 2021GlobeNewsWire • 03/09/21
Liquidia Corporation Secures $20.5 Million Debt Facility with Silicon Valley BankGlobeNewsWire • 03/02/21
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Liquidia Corporation and Encourages Investors with Losses of $100,000 to Contact the FirmBusiness Wire • 01/04/21
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Liquidia Corporation and Encourages Investors with Losses of $100,000 to Contact the FirmBusiness Wire • 12/31/20
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Announces Investigation of Securities Claims Against Liquidia Corporation – LQDABusiness Wire • 12/31/20
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia Corporation - LQDAGlobeNewsWire • 12/20/20
Liquidia Receives Complete Response Letter from FDA for LIQ861 (treprostinil) Inhalation Powder for the Treatment of Pulmonary Arterial HypertensionGlobeNewsWire • 11/25/20
Liquidia to Present at the 2020 Jefferies Virtual London Healthcare ConferenceGlobeNewsWire • 11/12/20
Liquidia Technologies, Inc. (LQDA) CEO Neal Fowler on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/09/20
Liquidia Reports Third Quarter 2020 Financial Results and Provides Corporate UpdateGlobeNewsWire • 11/09/20
Liquidia Reschedules Special Meeting of Stockholders and Reaffirms Recommendation to Approve Proposed Acquisition of RareGen, LLCGlobeNewsWire • 11/02/20
UPDATE – Liquidia to Report Third Quarter 2020 Financial Results and Provide Corporate Update on November 6, 2020GlobeNewsWire • 10/31/20